» Articles » PMID: 29967835

Factors Favouring the Development of Clostridium Difficile Infection in Critically Ill Patients

Overview
Publisher Sciendo
Specialty Critical Care
Date 2018 Jul 4
PMID 29967835
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: Assessment of favouring factors of Clostridium difficile infections as well as the interactions between them, in critically ill hospitalized patients undergoing complex medical and surgical treatments.

Material And Methods: A retrospective case-control study involving eighty patients admitted in the Intensive Care Unit (ICU) of the County Clinical Emergency Hospital Tîrgu-Mureş was conducted between January and October 2014. Patients aged eighteen years and over, who had undergone complex medical and surgical treatment, were divided into two subgroups. Group 1 included patients who developed diarrhoea but were not diagnosed as having a Clostridium difficile infection (CDI). Group 2 included patients who developed diarrhoea due to CDI as indicated by a positive culture and the expression of exotoxin. The assessed parameters were age, length of stay (LOS), antibiotic spectrum, association with proton pump inhibitors (PPI) or H2-receptor antagonists, immunological status, the presence or lack of gastrointestinal tract surgery.

Results: The mean age was 64.6 years with an average LOS of 10 days. Fifty-six percent of patients came to the ICU from internal medicine wards and forty-three percent from surgical wards. 20.5% of them were immunosuppressed. Co-association of ceftriaxone and pantoprazole significantly increased the risk of CDI compared to co-administration of any other antibiotic or pantoprazole (p=0.01). The odds ratio for Pantoprazole together with any antibiotic versus antibiotic therapy alone was significantly higher (p=0.018) with a sevenfold increase in the risk of positive exotoxin increase.

Conclusions: Antibiotic use is associated with "no risk to develop CDI" in the first five days of administration. PPIs associated therapy increased the risk of CDI in first seventy-two hours regardless of the antibiotic type, and contributes to an active expression of CD exotoxin.

Citing Articles

Clostridioides difficile infections in the intensive care unit: a monocentric cohort study.

Aguilar R, Salmanton-Garcia J, Carney J, Boll B, Kochanek M, Jazmati N Infection. 2020; 48(3):421-427.

PMID: 32212102 PMC: 7256083. DOI: 10.1007/s15010-020-01413-8.


Toxic Megacolon - A Three Case Presentation.

Dumitru I, Dumitru E, Rugina S, Tuta L J Crit Care Med (Targu Mures). 2018; 3(1):39-44.

PMID: 29967870 PMC: 5769890. DOI: 10.1515/jccm-2017-0008.

References
1.
Pepin J, Saheb N, Coulombe M, Alary M, Corriveau M, Authier S . Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005; 41(9):1254-60. DOI: 10.1086/496986. View

2.
Klingensmith M, Neville L, Delpire E, Wolfe M, Soybel D . Gastrin-mediated effects of omeprazole on rat colon mucosa. Surgery. 1999; 126(2):272-8. View

3.
Dubberke E, Reske K, Yan Y, Olsen M, McDonald L, Fraser V . Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis. 2008; 45(12):1543-9. DOI: 10.1086/523582. View

4.
Linsky A, Gupta K, Lawler E, Fonda J, Hermos J . Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med. 2010; 170(9):772-8. DOI: 10.1001/archinternmed.2010.73. View

5.
Walters P, Zuckerbraun B . Clostridium difficile infection: clinical challenges and management strategies. Crit Care Nurse. 2014; 34(4):24-34. DOI: 10.4037/ccn2014822. View